1. Home
  2. ORIC vs VRNT Comparison

ORIC vs VRNT Comparison

Compare ORIC & VRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • VRNT
  • Stock Information
  • Founded
  • ORIC 2014
  • VRNT 1994
  • Country
  • ORIC United States
  • VRNT United States
  • Employees
  • ORIC N/A
  • VRNT N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • VRNT EDP Services
  • Sector
  • ORIC Health Care
  • VRNT Technology
  • Exchange
  • ORIC Nasdaq
  • VRNT Nasdaq
  • Market Cap
  • ORIC 1.1B
  • VRNT 1.2B
  • IPO Year
  • ORIC 2020
  • VRNT N/A
  • Fundamental
  • Price
  • ORIC $12.20
  • VRNT $20.32
  • Analyst Decision
  • ORIC Strong Buy
  • VRNT Hold
  • Analyst Count
  • ORIC 8
  • VRNT 6
  • Target Price
  • ORIC $17.86
  • VRNT $25.60
  • AVG Volume (30 Days)
  • ORIC 1.1M
  • VRNT 1.4M
  • Earning Date
  • ORIC 11-13-2025
  • VRNT 12-03-2025
  • Dividend Yield
  • ORIC N/A
  • VRNT N/A
  • EPS Growth
  • ORIC N/A
  • VRNT 10.62
  • EPS
  • ORIC N/A
  • VRNT 0.74
  • Revenue
  • ORIC N/A
  • VRNT $893,843,000.00
  • Revenue This Year
  • ORIC N/A
  • VRNT $7.73
  • Revenue Next Year
  • ORIC N/A
  • VRNT $5.67
  • P/E Ratio
  • ORIC N/A
  • VRNT $27.56
  • Revenue Growth
  • ORIC N/A
  • VRNT N/A
  • 52 Week Low
  • ORIC $3.90
  • VRNT $14.15
  • 52 Week High
  • ORIC $14.93
  • VRNT $34.80
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 46.07
  • VRNT 54.91
  • Support Level
  • ORIC $12.02
  • VRNT $20.26
  • Resistance Level
  • ORIC $13.04
  • VRNT $20.31
  • Average True Range (ATR)
  • ORIC 0.75
  • VRNT 0.03
  • MACD
  • ORIC -0.12
  • VRNT 0.00
  • Stochastic Oscillator
  • ORIC 20.69
  • VRNT 72.22

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About VRNT Verint Systems Inc.

Verint Systems Inc with its subsidiaries, helps brands provide Boundless customer experience (CX) automation. AI offers a solution, and that's where Verint comes in. It empowers brands with groundbreaking AI via a next-gen open platform. Its Verint Open Platform helps organizations increase CX automation to achieve their strategic objectives and realize ROI. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: